Previous studies have reported the expression of CX3CL1 in squamous cell lung cancer tissues by immunohistochemistry 21,19, in which the location of this chemokine cannot be discriminated between the membrane, cytoplasm and nucleus, because in the case of IHC, counterstaining that masks the nuclei are frequently used. This evidence concerns the gene CX3CL1 and squamous cell lung carcinoma.